PAREXEL International appointed Maykin Ho to its Board of Directors
– USA, MA – PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that its Board of Directors have elected Maykin Ho, Ph.D.,…